Hakkaart-van Roijen L - Search Results

1

Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review.

van Steenbergen-Weijenburg KM, van der Feltz-Cornelis CM, Horn EK, van Marwijk HW, Beekman AT, Rutten FF, Hakkaart-van Roijen L. van Steenbergen-Weijenburg KM, et al. BMC Health Serv Res. 2010 Jan 19;10:19. doi: 10.1186/1472-6963-10-19. BMC Health Serv Res. 2010. PMID: 20082727 Free PMC article. Review.

2

Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment.

Schawo S, Hoefman R, Reckers-Droog V, Lawerman-van de Wetering L, Kaminer Y, Brouwer W, Hakkaart-van Roijen L. Schawo S, et al. Among authors: hakkaart van roijen l. Eur J Health Econ. 2023 Sep 27. doi: 10.1007/s10198-023-01633-3. Online ahead of print. Eur J Health Econ. 2023. PMID: 37755542

3

The burden of illness of hypopituitary adults with growth hormone deficiency.

Hakkaart-van Roijen L, Beckers A, Stevenaert A, Rutten FF. Hakkaart-van Roijen L, et al. Pharmacoeconomics. 1998 Oct;14(4):395-403. doi: 10.2165/00019053-199814040-00006. Pharmacoeconomics. 1998. PMID: 10344907

4

Cost of illness in adult patients with hypopituitarism.

Ehrnborg C, Hakkaart-Van Roijen L, Jonsson B, Rutten FF, Bengtsson BA, Rosén T. Ehrnborg C, et al. Pharmacoeconomics. 2000 Jun;17(6):621-8. doi: 10.2165/00019053-200017060-00008. Pharmacoeconomics. 2000. PMID: 10977399

5

Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.

Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY. Touw CR, et al. Br J Dermatol. 2001 May;144(5):967-72. doi: 10.1046/j.1365-2133.2001.04183.x. Br J Dermatol. 2001. PMID: 11359382 Clinical Trial.

6

The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.

Hakkaart-van Roijen L, Verboom P, Redekop WK, Touw KR, Rutten FF. Hakkaart-van Roijen L, et al. Pharmacoeconomics. 2001;19(5 Pt 2):599-608. doi: 10.2165/00019053-200119050-00013. Pharmacoeconomics. 2001. PMID: 11465304 Clinical Trial.

7

A cost study of a general practitioner hospital in the Netherlands.

Hakkaart-van Roijen L, Moll van Charante EP, Bindels PJ, Yzermans CJ, Rutten FF. Hakkaart-van Roijen L, et al. Eur J Gen Pract. 2004 Jun;10(2):45-9. doi: 10.3109/13814780409094231. Eur J Gen Pract. 2004. PMID: 15232523

8

The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands.

Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF. Hakkaart-van Roijen L, et al. Acta Psychiatr Scand. 2004 Nov;110(5):383-92. doi: 10.1111/j.1600-0447.2004.00403.x. Acta Psychiatr Scand. 2004. PMID: 15458562

9

Influence of waiting time on cost-effectiveness.

Koopmanschap MA, Brouwer WB, Hakkaart-van Roijen L, van Exel NJ. Koopmanschap MA, et al. Soc Sci Med. 2005 Jun;60(11):2501-4. doi: 10.1016/j.socscimed.2004.11.022. Epub 2004 Dec 16. Soc Sci Med. 2005. PMID: 15814175

10

Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial.

Horn EK, van Benthem TB, Hakkaart-van Roijen L, van Marwijk HW, Beekman AT, Rutten FF, van der Feltz-Cornelis CM. Horn EK, et al. BMC Health Serv Res. 2007 Feb 26;7:28. doi: 10.1186/1472-6963-7-28. BMC Health Serv Res. 2007. PMID: 17324283 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page